Rep. Ro Khanna and his spouse reported roughly $24,000 in transactions involving medical device giant SYK between late February and the end of March, according to new congressional trade disclosures.
The trades, spanning five weeks, show a quick in-and-out pattern in Stryker Corp., a $128.9 billion company traded on the New York Stock Exchange. Shares recently closed at $336.77, near the lower end of their 52-week range of $328.23 to $404.87.
A Short-Term Position
The disclosures detail three transactions:
- Feb. 24, 2026: Buy, $1,000–$15,000 (reported as DC)
- Mar. 23, 2026: Sell, $1,000–$15,000 (Spouse)
- Mar. 30, 2026: Sell, $1,000–$15,000 (DC)
All transactions fall within the standard congressional reporting bands, which disclose ranges rather than exact amounts. Based on those filings, the total value of activity during the period is estimated at about $24,000.
The structure suggests a brief holding period of less than five weeks before the position was fully exited. Lawmakers are required under the STOCK Act to disclose securities transactions within 45 days, but they are not required to provide precise trade sizes.
Stryker’s Market Backdrop
Stryker is one of the country’s largest medical technology companies, manufacturing orthopedic implants, surgical equipment, and hospital devices. The stock has faced pressure in recent months, hovering just above its 52-week low. Shares remain roughly 17% below their 52-week high of $404.87.
The late-February purchase came as the broader health care sector traded unevenly amid interest rate uncertainty and hospital spending concerns. By late March, when the sales occurred, SYK was still near the lower end of its annual range.
Khanna serves on the House Armed Services Committee and the House Committee on Oversight and Government Reform, along with the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party. While those panels do not directly regulate medical device manufacturers, Armed Services has jurisdiction over military health systems and procurement matters that can intersect with large health care suppliers.
Broader Congressional Interest
Stryker is not an obscure holding on Capitol Hill. At least 40 lawmakers have reported trading the stock, making it a relatively common name in congressional portfolios. Its size, liquidity, and position within the defensive health care sector often attract diversified investors.
Khanna has disclosed 17,672 trades over his congressional career, reflecting activity across a broad set of equities and funds. The Stryker transactions represent a small fraction of that total but add to an active 2026 trading ledger.
For readers tracking latest congressional trades, the brief SYK position stands out less for its size than for its rapid turnaround — a buy followed by two staggered sales within a month.
Whether the move captured a short-term rebound or simply reduced exposure amid volatility, the filings show the Khanna household entered and exited Stryker as the stock hovered near yearly lows, closing the position before April began.